Login to view
Course Activities.
|
Title: |
Activity/Course #: |
Cost: |
Release/Start Date: |
Expiration Date: |
Topics: |
Target Audience: |
Medium/Method: |
Estimated Time To Complete CME Activity: |
Hardware/Software Requirements: |
Credits: |
|
This webcast was captured live at the NACE New Perspectives in the Management of the Rheumatic Diseases: Applying Research to Practice-Update 2007 conference series and features Dr. Brown. Dr. Brown is Associate Professor of Medicine, Division of Rheumatology and Immunology. He is Vice Chairman for Education, Department of Medicine at the Medical University of South Carolina. Learning Objective(s): After completing this program participants should be able to explain the use of second signal inhibitor, abatacept, in treating Rheumatoid Arthritis. This webcast was recorded live and is being used with the permission of the presenter.
|
|
|
National Association for Continuing Education
|
| The National Association for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The National Association for Continuing Education designates this educational activity for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity. |
|
Alan Brown, MD made the following disclosures:
Speaker's Bureau—Abbott Laboratories
Charles Kahn, MD, Course Director, made the following disclosures:
Speaking Engagements – Eli Lilly, Pfizer, P&G, Abbott.
Elaine Kahn, MSN, ARNP, Course Director, made the following disclosures:
Speaking Engagements – Eli Lilly, Pfizer, P&G, Abbott.
Wayne Riskin, MD, Course Director, has no relationships to disclose.
Harvey Parker, PhD, Activity Planning Committee, has no relationships to disclose.
Michelle Frisch, MPH, Activity Planning Committee, has no relationships to disclose.
Alan Goodstat, LCSW, Activity Planning Committee, has no relationships to disclose. |
|
No commercial support was provided for this enduring activity. The following companies provided commercial support for the live CME activity entitled New Perspectives in the Management of Rheumatic Diseases: Update 2007 held in Hollywood, Florida on September 8, 2007 during which this presentation was held:Abbott Laboratories, Actelion, Amgen,Bristol-MyersSquibb, Centocor, Ferring Pharmaceuticals, Genentech, Procter & Gamble, Sanofi-Aventis, Wyeth |
|
